Skip to main content

Carly Simon reveals Parkinson’s diagnosis: ‘Learning how to live with it’

Carly Simon announced she has Parkinson’s disease in a statement Monday that also revealed she was treated for basal cell carcinoma, a type of skin cancer.

The “You’re So Vain” singer said she received the Parkinson’s diagnosis after experiencing a decline in mobility.

“Eventually, there were periods when I could not walk without considerable help,” she said in the statement obtained by CBS News. “My family and I knew something more was going on.”

Simon, 83, said she has started treatment for the disease, which can cause stiffness, slowed movement, impaired balance, speech changes and tremors. There isn’t a known cure for Parkinson’s, but medications can ease some of the symptoms, according to the Mayo Clinic.

Simon said her medication helps with stiffness and other symptoms, but the severity of the neurodegenerative disorder still ebbs and flows.

“There is no tidy or predictable schedule to the illness. It does not consult my calendar before deciding what kind of day I am going to have,” she said. The singer also noted how Parkinson’s “can affect much more than the body,” sometimes causing “anxiety, depression, exhaustion, and apathy” as well.

She said experiencing the apathy that can accompany her disease has been “particularly strange.”

“You can find yourself lying there like a starfish drying in the sun, arms pointing in all directions, while nothing inside is telling you to get up, read, watch, write, sing, call someone, or do much of anything at all,” she said. “That has been one of the hardest things to explain. It is not simply sadness or laziness. It is as though the part of the brain that sends out invitations to participate in life has temporarily misplaced the guest list.”

Amid her Parkinson’s diagnosis and treatment, Simon was also treated for basal cell carcinoma on her face. She said the surgery to remove the cancer further isolated her, as it affected her appearance and made her self-conscious. 

“I have always been more critical of my appearance than anyone else could possibly imagine (check out the irony of having written “You’re So Vain.”), and this gave my inner critic quite a lot of new material,” she said.

But, at the same time, Simon was recording a new record — her first in 18 years — called “Comes in Waves.” It’s due for release next month. 

“Working on the music gave shape to days that did not always have much shape,” said Simon. “It gave me somewhere to go without having to leave the room. It reminded me that illness can change your life without becoming the whole of your life.”

Simon called Parkinson’s “difficult, frustrating, and sometimes frightening.”

“I am still learning how to live with it and how to accept it without feeling that I have surrendered something essential,” she said. “I am still writing, singing, imagining, laughing, worrying, remembering, and occasionally getting trapped in an overstuffed chair.”

Simon rose to prominence in the 1970s. She went on to win multiple Grammy Awards and was inducted into the Rock and Roll Hall of Fame in 2022.

Luigi Mangione hearing set to start amid discussions about possible guilty plea

▶ Watch Video: CBS News New York Luigi Mangione, accused in the 2024 killing of UnitedHealthcare CEO Brian Thompson, is in discussions about a possible plea deal on federal charges ahead of a court appearance Friday in New York City, sources familiar with the matter told CBS News.Mangione, 28, is set to appear at an 11 a.m. conference in U.S. District Court in Manhattan. That meeting is taking place after prosecutors and the defense team sent a letter to federal court Tuesday requesting Friday's conference. Plea discussions between federal prosecutors and defense attorneys have been ongoing and it's unclear if an agreement has been reached, sources told CBS News.CBS News New York's Alice Gainer is inside the courtroom Friday with the latest developments.   Mangione's defense attorneys entered the court at around 10:38 a.m. The gallery was not full when they arrived, with about four rows of press and two rows of members of the public. Thompson's family entered the courtroom at around 10:51 a.m. Thompson, a husband and father of two, was fatally shot while walking down the street in New York City. The killing was caught on surveillance video. Just before 11 a.m., the courtroom was mostly full. Mangione's defense and prosecutors could be seen speaking to one another. Attorneys for Mangione have not responded to CBS News New York's request for comment. A spokesperson for the U.S. Attorney for the Southern District of New York also declined to comment. "I expect plea negotiations to happen in every case, or certainly most cases," legal expert Richard Schoenstein said. Mangione faces both federal and state charges in connection with Thompson's death. He has pleaded not guilty in both trials.The federal charges carry a potential maximum life sentence, which Mangione could still face even if a federal plea deal is reached. "In the federal system, you don't agree to a sentence as part of a plea deal. You agree to a plea and the crime, and then it has to go to a sentencing hearing in front of the judge," Schoenstein said."Maybe both parties try to, either by a binding agreement or by a suggestion to the court, say, 'We want some sort of reduced sentence, less than the life in federal prison that was the possibility here,'" CBS News legal contributor Jessica Levinson said.If a plea deal is reached, it could have an impact on his state trial, which is set to begin next month. That's because of potential double jeopardy concerns. Double jeopardy refers to a law which says "a person may not be twice prosecuted for the same offense," although a number of exceptions are listed. "I would expect the defense to make some sort of motion to preclude further prosecution of the state case on the grounds that it is double jeopardy," Schoenstein said. "I think the question of whether or not it would be double jeopardy is open and complicated and subject to debate."That's because the federal charges have to do with stalking resulting in death and stalking through use of interstate facilities, whereas the state charges are for second-degree murder, a weapons charge, and a forged instrument charge."So the weapons and forged instrument charges would not be resolved by the federal plea, and arguably the intentional killing charge would not be resolved. I do think there's a serious question as to whether this would be double jeopardy," Schoenstein said. "In New York state, there's more robust protections for defendants around the double jeopardy laws. And so that could be a real issue here, at least one that would merit litigation, if not dismissal," CBS News legal analyst Caroline Polisi said.Schoenstein said a federal plea deal would "put some pressure on state prosecutors to reach a deal of their own, or to become part of the deal that is being negotiated between the feds and the defendant, and therefore it could resolve the case on a negotiated level."Schoenstein said it could also impact the defense strategy if the state case does go forward, "because if it does go forward he no longer has to worry about a federal trial down the road."Legal experts say the case's national attention and the supporters Mangione has gained could be a factor in the feds wanting to make a deal."You have a raised possibility of what we call juror nullification, wherein a jury gets seated and there's someone in there that just, regardless of hearing any of the evidence, is never going to vote to convict Luigi Mangione," Polisi said.It was unclear what charges Mangione would plead guilty to on Friday, and he could reverse his decision at the last minute.The start of his federal trial, if it moves forward, is set for January.
Read Next Story